AssetMark Inc’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.46K | Buy |
48
+22
| +85% | +$2.5K | ﹤0.01% | 2111 |
|
|
2025
Q1 | $2.73K | Sell |
26
-58
| -69% | -$6.1K | ﹤0.01% | 2113 |
|
|
2024
Q4 | $9K | Buy |
84
+54
| +180% | +$5.79K | ﹤0.01% | 1811 |
|
|
2024
Q3 | $3K | Buy |
30
+4
| +15% | +$400 | ﹤0.01% | 1805 |
|
|
2024
Q2 | $2.19K | Hold |
26
| – | – | ﹤0.01% | 1733 |
|
|
2024
Q1 | $1.9K | Buy |
+26
| New | +$1.9K | ﹤0.01% | 1591 |
|
|
2022
Q1 | – | Sell |
-32
| Closed | -$3K | – | 1671 |
|
|
2021
Q4 | $3K | Buy |
+32
| New | +$3K | ﹤0.01% | 1323 |
|
|
2020
Q4 | – | Sell |
-10
| Closed | -$1K | – | 1456 |
|
|
2020
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 1246 |
|
|
2020
Q2 | $1K | Sell |
10
-3,717
| -100% | -$372K | ﹤0.01% | 1184 |
|
|
2020
Q1 | $169K | Sell |
3,727
-314
| -8% | -$14.2K | ﹤0.01% | 513 |
|
|
2019
Q4 | $263K | Buy |
4,041
+3,533
| +695% | +$230K | ﹤0.01% | 502 |
|
|
2019
Q3 | $32K | Buy |
508
+498
| +4,980% | +$31.4K | ﹤0.01% | 809 |
|
|
2019
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1248 |
|
|
2019
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 1258 |
|
|
2018
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 1329 |
|
|
2018
Q3 | $2K | Hold |
10
| – | – | ﹤0.01% | 1274 |
|
|
2018
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1348 |
|
|
2018
Q1 | $1K | Sell |
10
-1,683
| -99% | -$168K | ﹤0.01% | 1344 |
|
|
2017
Q4 | $145K | Buy |
1,693
+1,305
| +336% | +$112K | ﹤0.01% | 512 |
|
|
2017
Q3 | $33K | Sell |
388
-22
| -5% | -$1.87K | ﹤0.01% | 809 |
|
|
2017
Q2 | $31K | Sell |
410
-2
| -0.5% | -$151 | ﹤0.01% | 796 |
|
|
2017
Q1 | $27K | Sell |
412
-48
| -10% | -$3.15K | ﹤0.01% | 792 |
|
|
2016
Q4 | $29K | Buy |
460
+5
| +1% | +$315 | ﹤0.01% | 772 |
|
|
2016
Q3 | $29K | Sell |
455
-52
| -10% | -$3.31K | ﹤0.01% | 767 |
|
|
2016
Q2 | $38K | Buy |
507
+286
| +129% | +$21.4K | ﹤0.01% | 668 |
|
|
2016
Q1 | $15K | Buy |
221
+191
| +637% | +$13K | ﹤0.01% | 802 |
|
|
2015
Q4 | $2K | Buy |
+30
| New | +$2K | ﹤0.01% | 1104 |
|